Lee Golden
Chief Tech/Sci/R&D Officer at PTC THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-02-28
Profile
Currently, Lee Scott Golden occupies the position of Chairman at Coagulation Sciences LLC and Chief Medical Officer at PTC Therapeutics, Inc.
In his past career he was Medical Director for Pfizer Inc., Head-Pulmonary at Mesoblast Ltd., Chief Medical Officer for Gemphire Therapeutics, Inc., Head-Cardiovascular & Blood Disorders at Eisai, Inc. and Senior Director-US Medical at Actelion Pharmaceuticals US, Inc.
Lee Scott Golden received a doctorate from New York University School of Medicine and an undergraduate degree from the University of Michigan.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PTC THERAPEUTICS, INC.
0.08% | 2024-02-14 | 60,514 ( 0.08% ) | 2 M $ | 2024-02-28 |
Lee Golden active positions
Companies | Position | Start |
---|---|---|
PTC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Coagulation Sciences LLC
Coagulation Sciences LLC Medical/Nursing ServicesHealth Services Coagulation Sciences LLC engages in the provision of blood-testing innovation solutions. It offers multiple coagulation test systems, and benefits. The company was founded by Sheldon Goldstein and is headquartered in New York, NY. | Chairman | - |
Former positions of Lee Golden
Companies | Position | End |
---|---|---|
NEUROBO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-09-17 |
MESOBLAST LIMITED | Corporate Officer/Principal | 2016-09-30 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | 2011-06-30 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 2008-02-29 |
PFIZER, INC. | Chief Tech/Sci/R&D Officer | 2004-12-31 |
Training of Lee Golden
University of Michigan | Undergraduate Degree |
New York University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
PFIZER, INC. | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
MESOBLAST LIMITED | Health Technology |
Private companies | 4 |
---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
Coagulation Sciences LLC
Coagulation Sciences LLC Medical/Nursing ServicesHealth Services Coagulation Sciences LLC engages in the provision of blood-testing innovation solutions. It offers multiple coagulation test systems, and benefits. The company was founded by Sheldon Goldstein and is headquartered in New York, NY. | Health Services |
Gemphire Therapeutics, Inc.
Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |